tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Financial Statements

Compare
2,132 Followers

Aquestive Therapeutics Financial Overview

Aquestive Therapeutics's market cap is currently $298.59M. The company's EPS TTM is $-0.517; its P/E ratio is ―; Aquestive Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 57.56M$ 50.58M$ 47.68M$ 50.83M$ 45.85M
Gross Profit$ 39.69M$ 29.75M$ 28.29M$ 35.84M$ 32.88M
Operating Income$ -30.77M$ -15.10M$ -42.07M$ -34.68M$ -42.89M
EBITDA$ -26.62M$ 1.18M$ -39.58M$ -45.11M$ -39.15M
Net Income$ -44.14M$ -7.87M$ -60.20M$ -90.04M$ -65.36M
Balance Sheet
Cash & Short-Term Investments$ 71.55M$ 23.87M$ 27.27M$ 28.02M$ 31.81M
Total Assets$ 101.42M$ 57.42M$ 55.67M$ 61.99M$ 62.88M
Total Debt$ 38.00M$ 33.32M$ 56.09M$ 56.42M$ 40.48M
Net Debt$ -33.54M$ 9.45M$ 28.82M$ 28.40M$ 8.67M
Total Liabilities$ 161.58M$ 163.91M$ 174.23M$ 144.13M$ 111.38M
Stockholders' Equity$ -60.16M$ -106.49M$ -118.55M$ -82.13M$ -48.50M
Cash Flow
Free Cash Flow$ -35.92M$ -7.38M$ -12.31M$ -33.89M$ -45.98M
Operating Cash Flow$ -35.76M$ -6.38M$ -9.79M$ -32.98M$ -45.46M
Investing Cash Flow$ -159.00K$ -995.00K$ -2.52M$ -913.00K$ -517.00K
Financing Cash Flow$ 83.59M$ 3.97M$ 11.56M$ 30.11M$ 28.46M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History

Aquestive Therapeutics Debt to Assets

Aquestive Therapeutics Cash Flow

Aquestive Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis